Skip to content

Preliminary study on the effect of functional food on Blood inflammatory marker in human

Preliminary study on the effect of functional food on Blood inflammatory marker in human - Preliminary study on the effect of functional food on Blood inflammatory marker in human

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036090
Enrollment
80
Registered
2019-03-06
Start date
2019-03-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Functional food, 4 weeks Food without functional food, 4 weeks

Sponsors

SUNTORY GLOBAL INNOVATION CENTER LIMITED
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Subjects whose are 40 <= years old < 65. (2) Subjects who can visit hospital on designated day. (3) Subject who is able to give written informed consent before the study.

Exclusion criteria

Exclusion criteria: (1) Subjects whose systolic blood pressure is less than 90mmHg (2) Females who are pregnant or lactating, and females who could become pregnant or lactating during test period (3) Subjects who donated 200 mL of blood and/or blood components within four weeks prior to the current study (4) Males whose blood was collected more than 400 mL within the last 12 weeks (5) Females whose blood was collected more than 400 mL within the last 16 weeks (6) Males whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added (7) Females whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added (8) Subjects who are participating in other clinical studies for drug medicine or food, or who finished clinical study within four weeks (9) Subjects who drink alcohol a lot (10) Subjects who have a habit of smoking (11) Subjects who are with treatment (12) Subjects who constantly use drug medicine (13) Subjects who are judged as unsuitable for the study by the principal investigator for other reasons

Design outcomes

Primary

MeasureTime frame
Blood inflammatory marker

Countries

Japan

Contacts

Public ContactTakatsugu Tsuchiya

SUNTORY GLOBAL INNOVATION CENTER LIMITED Research Institute

Takatsugu_Tsuchiya@suntory.co.jp050-3182-0567

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026